Home
Search
Subscribe
Henry M. Jackson Foundation for the Advancement of Military Medicine
Advancing Military Medicine
Search Results - diagnostics
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Vaccines Against Fentanyl and Fentanyl Analogs - (HJF 561-19)
A technology related to novel fentanyl hapten compounds and their use in the preparation of vaccines against fentanyl and fentanyl analogs is available for licensing. Applications and Advantages Novel compounds for use as vaccines against fentanyl and analogs High immunogenicity that generates fentanyl specific antibodies to reduce its distribution...
Published: 10/17/2024
|
Updated: 3/27/2023
|
Inventor(s):
Gary Matyas
,
Oscar Torres
,
Kenner Rice
,
Eric Bow
,
Agnieszka Sulima
,
Arthur Jacobson
Keywords(s):
Antibody
,
Diagnostics
,
Fentanyl
,
Therapeutics
,
Vaccines
Category(s):
Diagnostics
,
Therapeutic
,
Vaccine
Urine-Based Prostate Cancer
Diagnostics
- (HJF 485-17)
A technology for screening and diagnosing prostate cancer based on urine exosomes is available for licensing from HJF. Applications and Advantages Screening for and diagnosis prostate cancer with superior accuracy than the standard of care. Convenience of using regular urine sample that can be collected at home, as opposed to post-DRE urine sample. RNA...
Published: 10/17/2024
|
Updated: 1/19/2023
|
Inventor(s):
Shiv Srivastava
,
Gyorgy Petrovics
,
Indu Kohaar
Keywords(s):
Diagnostics
,
Prostate Cancer
Category(s):
Diagnostics
Shark Antibodies and Shark-Derived Binding Domains Specific for the SARS-CoV-2 Coronavirus - (HJF 581-20)
HJF scientists have developed a series of single variable domain antibodies (nanobodies or VNARs, derived from nurse sharks) specifically targeting SARS-CoV-2 and other betacoronaviruses, thus providing unique therapeutics and
diagnostics
for COVID-19 and possibly other betacoronavirus infections. Applications and Advantages Fully sequenced, grafted...
Published: 10/17/2024
|
Updated: 5/20/2022
|
Inventor(s):
Michael Gordon Joyce
,
Kayvon Modjarrad
,
Helen Dooley
Keywords(s):
Antibody
,
Coronavirus
,
COVID-19
,
Diagnostics
,
Sarbecovirus
,
SARS-CoV-2
,
Therapeutics
Category(s):
Therapeutic
,
Diagnostics